Manuela Terrinoni

Cholera Toxin, and the Related Nontoxic Adjuvants mmCT and dmLT, Promote Human Th17 Responses via Cyclic AMP–Protein Kinase A and Inflammasome-Dependent IL-1 Signaling

Maximilian Larena, Jan Holmgren, Michael Lebens et al. · The Journal of Immunology · 2015 · 72 citations

Life Sciences, Immunology, Toxicology +17

Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae

Michael Lebens, Manuela Terrinoni, Stefán Karlsson et al. · Vaccine · 2016 · 40 citations

Life Sciences, Biotechnology, Infectious Diseases +16

Deficiency in Calcium-Binding Protein S100A4 Impairs the Adjuvant Action of Cholera Toxin

Jia-Bin Sun, Jan Holmgren, Maximilian Larena et al. · Frontiers in Immunology · 2017 · 23 citations · Full text

Life Sciences, Immunology, Pathology +17

Generation of Human Single-chain Antibody to the CD99 Cell Surface Determinant Specifically Recognizing Ewing’s Sarcoma Tumor Cells

Mara Gellini, Alessandro Ascione, Michela Flego et al. · Current Pharmaceutical Biotechnology · 2013 · 21 citations

Pharmacy, Molecular Biology, Oncology +17

Requirement for Cyclic AMP/Protein Kinase A-Dependent Canonical NFκB Signaling in the Adjuvant Action of Cholera Toxin and Its Non-toxic Derivative mmCT

Manuela Terrinoni, Jan Holmgren, Michael Lebens et al. · Frontiers in Immunology · 2019 · 14 citations · Full text

Life Sciences, Cell Biology, Immunology +17